This work presents a novel method for directly forming highly-oriented Mg–Fe–CO3 LDH coating on pure Mg samples by treating the sample in pH 5.6 aqueous Fe3+/HCO3−/CO32− at 50 °C, and then immersing it in pH 9.5 aqueous HCO3−/CO32− at 50 °C. The former step was performed to yield Mg2+ in aqueous solution at pH 5.6 by corroding the Mg sample. A two-layered thin film was thus formed on the Mg substrate, of which the outer layer (∼1 μm-thick) comprised fine platelet-like Mg–Fe–CO3 LDH. The latter treatment in pH 9.5 aqueous HCO3−/CO32− at 50 °C resulted in the growth of the fine LDH platelets into a strongly-oriented Mg–Fe–CO3 LDH. The chemical formula of the Mg–Fe–CO3 LDH is Mg0.74Fe0.26(OH)2(CO3)0.13·mH2O. The method used herein involves a metal salt-free system, which requires no addition of Mg(NO3)2 and Fe(NO3)3. Several in vitro tests of the Mg–Fe–CO3 LDH coating on a Mg sample were performed. Based on the measured contact angle between the sample surface and human whole blood, the Mg–Fe–CO3 LDH coating can improve the hydrophilicity of a pure Mg surface. According to the results of an in vitro corrosion test in revised simulated body fluid (R-SBF), the Mg–Fe–CO3 LDH coated sample had a much higher corrosion resistance than the pure Mg substrate. The results of in vitro human mesenchymal stem cell adhesion tests showed that the Mg–Fe–CO3 LDH coated sample had a better cell spreading and cell–cell interaction behavior than the pure Mg substrate.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: